Загрузка...
Insulin Secretion Improves in Cystic Fibrosis Following Ivacaftor Correction of CFTR: A Small Pilot Study
OBJECTIVE: To determine whether the cystic fibrosis transmembrane conductance regulator (CFTR) is involved in human insulin secretion by assessing the metabolic impact of the new CFTR corrector, ivacaftor. METHODS: This open-label pilot study was conducted in CF patients with the G551D mutation give...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804832/ https://ncbi.nlm.nih.gov/pubmed/23952705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pedi.12026 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|